Pharmaceutical Intermediates Market Is Expected To Reach US$ 36,890.6 Mn By 2027 | Credence Research
The latest market report published by Credence Research, Inc. “Global Pharmaceutical Intermediates Market By Product (Bulk Drug Intermediates, Chemical Intermediates, Custom Intermediates), By End User (Pharmaceutical & Biotechnology Companies, Contract Manufacturing Organization, Research Laboratories) — Growth, Future Prospects & Competitive Analysis, 2019–2027,” the global pharmaceutical intermediates market was valued at US$ 25,965.0 Mn in 2018, and is expected to reach US$ 36,890.6 Mn by 2027, expanding at a CAGR of 4.0% from 2019 to 2027.
Browse the full report at https://www.credenceresearch.com/report/pharmaceutical-intermediates-market
Pharmaceutical intermediates are manufactured by chemical processing of synthetic and natural resources which finds diverse application in life science industries. Incessant rise in patient population actively seeking medication and flourishing pharmaceutical & biotechnology companies throughout the globe together drive the pharmaceutical intermediates market growth.
Bulk drug intermediates are spearheading the product segment for pharmaceutical intermediates market. Significant rise in drug formulation research & development (FR&D) activities provides necessary impetus for its market growth. They are used as raw material or as a secondary product generated during the synthesis of active pharmaceutical ingredient (API) having potential to be used in various drug formulation. Custom intermediates are gaining huge traction owing to the increased drug development and research activities.
Pharmaceutical & biotechnology companies are leading the end user segment for pharmaceutical intermediates market. The major factors contributing towards its excellent market growth are rising prevalence of life threatening diseases and stringent regulatory norms pertaining to cGMP and cGLP of drug manufacturing sanctioned by healthcare agencies worldwide. In the last 2 decades research laboratories highlighted good market growth owing to the increasing demand of pharmaceutical intermediates in developing novel medicines for the treatment of rare and autoimmune diseases. Contract manufacturing organization will be growing at a rapid pace on account of significant rise in drug manufacturing outsourcing activities to penetrate untapped market throughout the globe.
Download Free PDF Sample Request: https://www.credenceresearch.com/sample-request/59749
North America with a market share of 35.8% is dominating the regional segment for pharmaceutical intermediates market. The major factors propelling its market growth are rising public health awareness and presence of a well developed healthcare infrastructure. Europe is trailing North America in the regional market representing a market share of 30.4% market share on account of increasing patient population seeking medical intervention for life threatening diseases and supportive regulatory environment provided by European Medical Agency (EMA). Asia Pacific is holding 20.2% market share owing to proactive government policies favoring flourishing growth of pharmaceutical and biotechnology companies and lucrative market opportunity for key vendors to enter into strategic agreement and collaboration with regional players for manufacturing of generic drugs in Asia Pacific region.
Companies producing pharmaceutical intermediates are BASF SE, Bristol Myers Squibb Company, Cambrex Corporation, Chiracon GmbH, Codexis, Inc., Dishman Group, Dextra Laboratories, Ltd., Lonza, Midas Pharma GmbH and Vertellus Holdings LLC.
Key Market Movements:
- Rising prevalence of life threatening diseases
- Supportive regulatory environment provided by global healthcare agencies
- Significant rise in drug formulation research & development (FR&D) activities and expiration of blockbuster drug patent to provide necessary impetus for generic drug production
By Product (2017–2027; US$ Mn)
- Bulk Drug Intermediates
- Chemical Intermediates
- Custom Intermediates
By End User (2017–2027; US$ Mn)
- Pharmaceutical and Biotechnology Companies
- Contract Manufacturing Organization
- Research Laboratories
Geography Segment (2017–2027; US$ Mn)
- North America
- United States
- United Kingdom
- Rest of Europe
- Asia Pacific
- Rest of Asia Pacific
- Latin America (LATAM)
- Rest of Latin America
- Middle East and Africa (MEA)
- Rest of MEA
Do Inquiry before Buying for this report at https://www.credenceresearch.com/inquiry-before-buying/59749